Background and Aims: Physical inactivity is an important feature for COPD patients. To evaluate physical activity (PA), two major methods, that is, direct method and questionnaire are applicable. We evaluated physical activity in patients with COPD cross-sectionally and longitudinally using LSA (Life space assessment) score, which is one of questionnaires for PA. The aim of this study is to evaluate the factors which affect physical activity.
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Methods: We enrolled 162 stable subjects from Kyoto University Hospital outpatient clinic. They took interview, pulmonary function test, and questionnaires such as mMRC, CAT, LSA, and PHQ9 (depression assessment). After one year, we performed same assessment again, to evaluate longitudinal changes of each index.
Results: Finally, 152 patients (male : female = 143 : 9, median age 71, median %FEV1 63.9) were analyzed cross-sectionally. LSA significantly correlated with age, %DLCO, mMRC, CAT, PHQ9 and weakly with %FRC (P = 0.06). And age, PHQ9 and CAT were significant determinants in multivariate analysis. In longitudinal analysis, LSA changes correlated with %FRC changes only.
Conclusion:
Patients' physical activity is affected by symptoms and mental status, on the other hand, hyperinflation could be most important functional factor on changes of physical activity. In this point of view, deflation by pharmacological and/or non-pharmacological approach is important for maintain physical activity in COPD patients. Background and Aims: Despite the strong evidence behind pulmonary rehabilitation PR, the programme is still not well attended by people living with chronic respiratory illnesses. The need for a new PR approach was required. The home based programme was chosen as the alternative approach to be piloted and analysed for its effects.
Methods: Ten-week prospective interventional cohort study
The home based patients were given an information pack. The patients were instructed to do the exercises according to the "Move on up" DVD. Patients were asked to complete the walking diary, ideally on a daily basis for the duration of the programme. The patients were informed that there would be a weekly contact to maintain their motivation in the programme and answer any questions they came up during the programme.
Results: 21 participants were successfully recruited from the pool of previous participants who had withdrawn from the Canterbury PR service.
The control group was a random selection of 70 previous participants who had completed the centre based Canterbury PR. ÁThe mean age for the home-based group was significantly younger than the control group by almost 6 years. ÁThe home-based programme appeared more effective in reaching the New Zealand M aori community when compared to the control group. ÁThe home-based programme performed equally well in achieving significant improvement in all of the outcome measures (P < 0.05).
This study has successfully demonstrated that homebased PR is an effective alternative to the gold standard centre-based PR when managing people living with COPD. Despite the fact that the homebased group participants were recruited from a harder to engage and more severe group, the home-based PR was an enabler to positive and significant improvements to the participants in all outcome measures. Methods: We used two mouse emphysema models, elastaseinduced model and cigarette smoke-induced model. Into the mice, we intravenously injected WJMCSs (1 × 10 4 /mouse) pretreated with or without pioglitazone for 7 days. We measured the emphysema severity by mean linear intercepts (MLI) analysis using lung histology. We compared the mice treated with pioglitazone-augmented WJMSCs (pioWJMSCs) to the mice treated with none-augmented WJMSCs as well as to the control mice with no treatment of WJMSCs.
Results: Pioglitazone-augmented WJMSCs appeared more regeneration of lung emphysema than none-augmented WJMSCs in the two mouse emphysema models. In the elastase-induced emphysema model, the MLIs were 59.0 AE .42 μm (n = 6), 72.8 AE .87 μm (n = 6), for pioglitazone-augmented WJMSCs treated mice, and none-augmented WJMSCs treated mice, respectively (P < 0.01). Both pioglitazone- 
